David M. Spencer, Chief Scientific Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 20,000 shares at $11.54 ($231K) on 2017-07-10, disclosed to the SEC on 2017-07-12.
Open-market sale of $231k BLCM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.54 | 10,000 | $115K | 50.0% |
| 2 | $11.54 | 10,000 | $115K | 50.0% |
| Total | $11.54 avg | 20,000 | $231K | 100% |
| Filing → |
| BLCM | SELL | 2016-12-05 | $100K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $139K | — | Filing → |
| BLCM | SELL | 2016-09-23 | $453K | — | Filing → |